Apathy is associated with activities of daily living ability in Parkinson's disease

Dementia and Geriatric Cognitive Disorders

Volumn 35, Issue 5-6, 2013, Pages 249-255

  Laatu, S ^a   Karrasch, M ^b   Martikainen, K ^c   Marttila, R ^c  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Activities of daily living; Apathy; Neuropsychiatric symptoms; Parkinson's disease

Indexed keywords

ADULT; AGED; AGITATION; ANXIETY; APATHY; ARTICLE; CORRELATION ANALYSIS; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE DURATION; FEMALE; HUMAN; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; NEUROPSYCHIATRY; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; ALZHEIMER DISEASE; CAREGIVER; CAREGIVER BURDEN; MOTOR DYSFUNCTION; NURSING HOME; QUALITY OF LIFE; RISK ASSESSMENT;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; APATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; REGRESSION ANALYSIS;

AMANTADINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; HYPNOTIC AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR;

EID: 84874814200     PISSN: 14208008     EISSN: 14219824     Source Type: Journal    
DOI: 10.1159/000347129     Document Type: Article

References (29)

1. Aarsland D, Marsh L, Schrag A: Neuropsychiatric symptoms in Parkinson's disease. Mov Disord 2009; 24: 2175-2186
2. Leiknes I, Tysnes O-B, Aarsland D, Larsen JP: Caregiver distress associated with neuropsychiatric problems in patients with early Parkinson's disease: The Norwegian Park West study. Acta Neurol Scand 2010; 122: 418-424
3. Aarsland D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, Cummings JL: Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999; 67: 492-496
4. Aarsland D, Cummings JL, Larsen JP: Neuropsychiatric differences between Parkinson's disease with dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001; 16: 184-191
5. Kulisevsky J, Pagonabarraga J, Pascual-Sedano B, García- Sánchez C, Gironell A: Prevalence and correlates of neuropsychiatric symptoms in Parkinson's disease without dementia. Mov Disord 2008; 23: 1889-1896
6. Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M: Caregiver-burden in parkinson's disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 2006; 12: 35-41
7. Edwards NE, Scheetz PS: Predictors of burden for caregivers of patients with Parkinson's disease. J Neurosci Nurs 2002; 34: 184-190
8. Karttunen K, Karppi P, Hiltunen A, Vanhanen M, Välimäki T, Martikainen J, Valtonen H, Sivenius J, Soininen H, Hartikainen S, Suhonen J, Pirttilä T: Neuropsychiatric symptoms and quality of life in patients with very mild and mild Alzheimer's disease. Int J Geriatr Psychiatry 2011; 26: 473-482
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ: Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184
10. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE: Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010; 25: 2649-2653
11. Fahn S, Elton RL: Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale; in Fahn S, Marsden CD, Calne DB, Lieberman A, (eds): Recent Development in Parkinson's Disease. Florham Park, Macmillan Health Care Information, 1987, pp 153-163
12. Folstein MF, Folstein SE, McHugh PR: 'Mini-mental state A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198
13. Cummings JL, Mega M, Gray K, Rosenberg Thompson S, Carusi DA, Gornbein J: The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314
14. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, Ferris S: An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord 1997; 11(suppl 2):33-39
15. Pedersen KF, Larsen JP, Alves G, Aarsland D: Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study. Parkinsonism Relat Disord 2009; 15: 295-299
16. Pedersen KF, Alves G, Brønnick K, Aarsland D, Tysnes O-B, Larsen JP: Apathy in drug-naïve patients with incident Parkinson's disease: The Norwegian Park West study. J Neurol 2010; 257: 217-223
17. Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, Craig AH, Paulsen JS, Litvan I: Apathy is not depression. J Neuropsychiatry Clin Neurosci 1998; 10: 314-319
18. Pluck GC, Brown RG: Apathy in Parkinson's disease. J Neurol Neurosurg Psychiatry 2002; 73: 636-642
19. Isella V, Melzi P, Grimaldi M, Iurlaro S, Piolti R, Ferrarese C, Frattola L, Appollonio I: Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease. Mov Disord 2002; 17: 366-371
20. Aalten P, Verhey FRJ, Boziki M, Brugnolo A, Bullock R, Byrne EJ, Camus V, Caputo M, Collins D, De Deyn PP, Elina K, Frisoni G, Holmes C, Hurt C, Maarriot A, Mecocci P, Nobili F, Ousset PJ, Reynish E, Salmon E, Tsolaki M, Vellas B, Robert PH: Consistency of neuropsychiatric syndromes across dementias: Results from the European Alzheimer Disease Consortium. Dement Geriatr Cogn Disord 2008; 25: 1-8
21. Skidmore FM, Yang M, Baxter L, von Deneen K, Collingwood J, He G, Tandon R, Korenkevych D, Savenkov A, Heilman KM, Gold M, Liu Y: Apathy, depression, and motor symptoms have distinct and separable resting activity patterns in idiopathic Parkinson disease. Neuroimage 2011, E-pub ahead of print
22. Chatterjee A, Fahn S: Metylphenidate treats apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2002; 14: 461-462
23. Drijgers RL, Aalten P, Winogrodzka A, Verhey FRJ, Leentjens AFG: Pharmacological treatment of apathy in neurodegenerative diseases: A systematic review. Dement Geriatr Cogn Disord 2009; 28: 13-22
24. Gómez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I, Bustos JL, Valle MA, Lezcano E, Zarranz JJ: Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease. J Neurol 2011; 258: 494-499
25. Rektorová I: Effects of dopamine agonists on neuropsychiatric symptoms of Parkinson's disease. Neurodegener Dis 2010; 7: 206-209
26. Mollenhauer B, Förstl H, Deuschl G, Storch A, Oertel W, Trenkwalder C: Lewy body and Parkinsonian dementia. Dtsch Arztebl Int 2010; 107: 684-691
27. Bickel S, Alvarez L, Macias R, Pavon N, Leon M, Fernandez C, Houghton DJ, Salazar S, Rodríguez-Oroz MC, Juncos J, Guridi J, DeLong M, Obeso JA, Litvan I: Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 535-539
28. Krack P, Hariz MI, Baunez C, Guridi J, Obeso JA: Deep brain stimulation: From neurology to psychiatry? Trends Neurosci 2010; 33: 474-484
29. Antonini A, Isaias IU, Rodolfi G, Landi A, Natuzzi F, Siri C,Pezzoli G: A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol 2011; 258: 579-585